RETRACTED: Metallothionein I+II expression and their role in experimental autoimmune encephalomyelitis

retracted paper

RETRACTED: Metallothionein I+II expression and their role in experimental autoimmune encephalomyelitis is …
instance of (P31):
scholarly articleQ13442814
retracted paperQ45182324

External links are
P356DOI10.1002/1098-1136(200012)32:3<247::AID-GLIA50>3.0.CO;2-T
P698PubMed publication ID11102966

P50authorMilena PenkowaQ3378367
Juan HidalgoQ37379782
P2860cites workYeast and mammalian metallothioneins functionally substitute for yeast copper-zinc superoxide dismutaseQ27933522
IL-6 deficiency leads to reduced metallothionein-I+II expression and increased oxidative stress in the brain stem after 6-aminonicotinamide treatmentQ28377943
Effect of non-toxic mercury, zinc or cadmium pretreatment on the capacity of human monocytes to undergo lipopolysaccharide-induced activationQ28378867
Enhanced seizures and hippocampal neurodegeneration following kainic acid-induced seizures in metallothionein-I + II-deficient miceQ31430351
Activation of the inducible form of nitric oxide synthase in the brains of patients with multiple sclerosisQ33642743
Spontaneous inflammatory demyelinating disease in transgenic mice showing central nervous system-specific expression of tumor necrosis factor alphaQ33771960
Aminoguanidine, an inhibitor of inducible nitric oxide synthase, ameliorates experimental autoimmune encephalomyelitis in SJL mice.Q34153407
Metallothionein protects against the cytotoxic and DNA-damaging effects of nitric oxideQ34334574
Molecular profile of reactive astrocytes--implications for their role in neurologic diseaseQ34366853
Elevated secretion of reactive nitrogen and oxygen intermediates by inflammatory leukocytes in hyperacute experimental autoimmune encephalomyelitis: enhancement by the soluble products of encephalitogenic T cellsQ36231527
Evidence for a protective role of metallothionein-1 in focal cerebral ischemiaQ36561063
Experimental autoimmune encephalomyelitis in rodents as a model for human demyelinating diseaseQ40411063
Metallothioneins and cell death by anticancer drugsQ40437026
Inflammation in EAE: role of chemokine/cytokine expression by resident and infiltrating cellsQ40944429
Role of macrophages/microglia in multiple sclerosis and experimental allergic encephalomyelitisQ41433234
Activation of human monocytes with lipopolysaccharide induces metallothionein expression and is diminished by zincQ41496402
Enhanced sensitivity to oxidative stress in cultured embryonic cells from transgenic mice deficient in metallothionein I and II genesQ42490264
Appearance of inducible nitric oxide synthase in the rat central nervous system after rabies virus infection and during experimental allergic encephalomyelitis but not after peripheral administration of endotoxinQ45785851
Local delivery of TNF by retrovirus-transduced T lymphocytes exacerbates experimental autoimmune encephalomyelitis.Q45937546
Myelin basic protein content of aggregating rat brain cell cultures treated with cytokines and/or demyelinating antibody: effects of macrophage enrichmentQ46845557
The protein thiol metallothionein as an antioxidant and protectant against antineoplastic drugsQ47785517
IL-6-deficient mice are resistant to the induction of experimental autoimmune encephalomyelitis provoked by myelin oligodendrocyte glycoproteinQ47914546
Interleukin-6 functions in autoimmune encephalomyelitis: a study in gene-targeted miceQ48035745
Activated non-neural specific T cells open the blood-brain barrier to circulating antibodiesQ48174524
Impaired inflammatory response to glial cell death in genetically metallothionein-I- and -II-deficient miceQ48245297
Effect of nitric oxide synthesis inhibition on mouse liver and brain metallothionein expressionQ48251392
Effect of reactive oxygen species on myelin membrane proteinsQ48448702
Increased astrocytic expression of metallothioneins I + II in brainstem of adult rats treated with 6-aminonicotinamideQ48549874
Reactive oxygen species in experimental allergic encephalomyelitisQ48712953
Selective degeneration of oligodendrocytes mediated by reactive oxygen species.Q50884032
Metallothionein (MT)-III: generation of polyclonal antibodies, comparison with MT-I+II in the freeze lesioned rat brain and in a bioassay with astrocytes, and analysis of Alzheimer's disease brains.Q53338345
IL-6 plays a crucial role in the induction phase of myelin oligodendrocyte glucoprotein 35-55 induced experimental autoimmune encephalomyelitis.Q54070701
P5824is retracted byRetracted: Metallothionein I+II expression and their role in experimental autoimmune encephalomyelitisQ56240171
P433issue3
P407language of work or nameEnglishQ1860
P921main subjectexperimental autoimmune encephalomyelitisQ494066
P304page(s)247-63
P577publication date2000-12-01
P1433published inGliaQ15716658
P1476titleRETRACTED: Metallothionein I+II expression and their role in experimental autoimmune encephalomyelitis
P478volume32

Reverse relations

cites work (P2860)
Q34361472Abnormalities in Cu and Zn levels in acute hepatitis of different etiologies.
Q43755784Altered inflammatory response and increased neurodegeneration in metallothionein I+II deficient mice during experimental autoimmune encephalomyelitis.
Q48622032Amyloid neurotoxicity is attenuated by metallothionein: dual mechanisms at work
Q31123558Astrocytic expression of the Alzheimer's disease beta-secretase (BACE1) is stimulus-dependent
Q39582687Correlation among metallothionein expression, intratumoural macrophage infiltration and the risk of metastasis in human cutaneous malignant melanoma.
Q58425792Endogenous leukemia inhibitory factor production limits autoimmune demyelination and oligodendrocyte loss
Q48475566Erythropoietin exerts an anti-inflammatory effect on the CNS in a model of experimental autoimmune encephalomyelitis
Q48405270Expression of metallothionein-I, -II, and -III in Alzheimer disease and animal models of neuroinflammation
Q38081955Glia-based biomarkers and their functional role in the CNS.
Q41875308Hepatic expression of metallothionein I/II, glycoprotein 96, IL-6, and TGF- β in rat strains with different susceptibilities to experimental autoimmune encephalomyelitis.
Q45015203Identification and characterization of metallothionein-1 and -2 gene expression in the context of (+/-)3,4-methylenedioxymethamphetamine-induced toxicity to brain dopaminergic neurons.
Q58027618Immune and Inflammatory Responses in the Central Nervous System: Modulation by Astrocytes
Q38797013Immunomodulation of cell-penetrating tat-metallothionein for successful outcome of xenotransplanted pancreatic islet
Q43261913Impaired synthesis of erythropoietin, glutamine synthetase and metallothionein in the skin of NOD/SCID/gamma(c)(null) and Foxn1 nu/nu mice with misbalanced production of MHC class II complex
Q36695714Inflammation, demyelination, neurodegeneration and neuroprotection in the pathogenesis of multiple sclerosis
Q33407201Keratinocytes as depository of ammonium-inducible glutamine synthetase: age- and anatomy-dependent distribution in human and rat skin
Q42163275Metallothionein 1+2 protect the CNS during neuroglial degeneration induced by 6-aminonicotinamide
Q34655359Metallothionein and a peptide modeled after metallothionein, EmtinB, induce neuronal differentiation and survival through binding to receptors of the low-density lipoprotein receptor family
Q48666444Metallothionein expression and oxidative stress in the brain
Q36793817Metallothionein in the central nervous system: Roles in protection, regeneration and cognition
Q37390245Metallothionein induction reduces caspase-3 activity and TNFalpha levels with preservation of cognitive function and intact hippocampal neurons in carmustine-treated rats
Q74582402Metallothionein suppresses collagen-induced arthritis via induction of TGF-beta and down-regulation of proinflammatory mediators
Q48363883Metallothionein-I overexpression decreases brain pathology in transgenic mice with astrocyte-targeted expression of interleukin-6.
Q44418999Metallothionein-IIA promotes initial neurite elongation and postinjury reactive neurite growth and facilitates healing after focal cortical brain injury.
Q45796618Metallothioneins I/II expression in rat strains with genetically different susceptibility to experimental autoimmune encephalomyelitis.
Q41984348Metallothioneins and brain injury: What transgenic mice tell us.
Q44364506Oral zinc aspartate treats experimental autoimmune encephalomyelitis
Q48305181Role of metallothionein-III following central nervous system damage
Q34317904Roles of the metallothionein family of proteins in the central nervous system
Q57374883The Physiological Roles of Extracellular Metallothionein
Q38800853The pharmacodynamics of antiplatelet compounds in thrombosis treatment
Q53659351Zinc aspartate suppresses T cell activation in vitro and relapsing experimental autoimmune encephalomyelitis in SJL/J mice.

Q56240171Retracted: Metallothionein I+II expression and their role in experimental autoimmune encephalomyelitismain subjectP921